CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
🔴 Connect Biopharma is trading 5% down today after mixed second-quarter results and a widening net loss
Connect Biopharma is trading 5% down now at $2.41 after mixed second-quarter results and a widened net loss. - Collaboration revenue: $2.8 million, above...
🟢 Connect Biopharma is trading 10.3% up today after Q2 EPS beat
Connect Biopharma is trading 10.3% up at $2.57 after reporting second-quarter 2026 results on August 12, including $2.8 million in milestone revenue and an EPS...
🟢 Connect Biopharma is trading 6.01% up today after Q2 collaboration revenue from Simcere regulatory milestone
Connect Biopharma is trading 6.01% up now at $2.47 after reporting second-quarter results with $2.8 million in collaboration revenue, versus minimal...
Connect Biopharma's second quarter 2026 results beat estimates as milestone revenue reached $2.8M
Connect Biopharma reported second quarter 2026 revenue of $2.8 million and a net loss per share of $0.27, outperforming consensus estimates. Results were...
🟢 Connect Biopharma is trading 5% up today ahead of August 12, 2026 earnings
Connect Biopharma is trading 5.13% up now at $2.35 after continued investor positioning ahead of the expected August 12, 2026, second-quarter earnings...
Connect Biopharma Surges 10% Before Earnings — But Can a Cash-Burning Biotech With No Revenue Justify the Optimism?
Shares of Connect Biopharma shifted sharply higher on August 11, climbing 10.7% to $2.38 ahead of the company's expected Q2 2026 earnings report on August 12....
🟢 Connect Biopharma is trading 10.7% up in pre-market ahead of its August 12, 2026 earnings report
Connect Biopharma is trading 10.7% up at $2.38 ahead of its Q2 2026 earnings report, expected on August 12, 2026. - Analysts expect a $0.32-per-share loss and...
Connect Biopharma Holdings Ltd Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Connect Biopharma is expected to report a Q2 2026 consensus loss of $0.32 per share on zero revenue, with the current $1.82 share price sitting significantly...
🟢 Connect Biopharma is trading 11.09% up in pre-market possibly ahead of August 12, 2026 earnings
Connect Biopharma is trading at $2.45 (+11.09%), with investors possibly positioning ahead of August 12, 2026 earnings. - No new company-specific announcement...
🟢 Connect Biopharma is trading 5.3% up today amid a broad biotech and risk-on rally
Connect Biopharma is trading 5.3% up at $2.18 today, extending its recent upside momentum amid a broad risk-on sentiment and a rally across biotech names. •...
🟢 Connect Biopharma is trading 8% up today amid broad risk-on sentiment
Connect Biopharma is trading at $2.24 (8% up) today, extending its recent upside amid broad risk-on sentiment and a macro-led rally. • The stock continues its...
🟢 Connect Biopharma is trading 6.1% up today amid a broad risk-on rally in U.S. equities
Connect Biopharma is trading at $2.09 (+6.09%) following a broad risk-on move in U.S. equities and supportive macro sentiment. • The move appears driven by...
🟢 Connect Biopharma is trading 5.8% up today amid ongoing risk-on sentiment and higher U.S. futures
Connect Biopharma is trading at $2.08 (5.8% up) in pre-market, extending a rebound seen late last week amid supportive macro risk-on sentiment and higher U.S....
🟢 Connect Biopharma is trading 5.5% up today amid broad risk-on sentiment
Connect Biopharma is trading 5.5% up at $2.13 in pre-market, extending the rebound seen late last week. • The move appears driven by supportive macro...
🟢 Connect Biopharma is trading 5.7% up today amid risk-on sentiment and broader market strength
Connect Biopharma is trading 5.7% up at $2.21 in pre-market, building on yesterday's modest gains and a stronger move in after-hours trading. • The stock's...
🟢 Connect Biopharma is trading 5.3% up today amid broader market strength
Connect Biopharma is trading at $2.20 (5.3% up) following a modest regular-session gain and a stronger move in after-hours trading. • The price action appears...
🟢 Connect Biopharma is trading 7.7% up today amid broader market momentum
Connect Biopharma is trading at $2.21 (+7.67%) in pre-market sessions, likely driven by broader market momentum as no company-specific news was identified to...
🟢 Connect Biopharma is trading 5.3% up today on thin after-hours liquidity
Connect Biopharma is trading at $2.19 (5.3% up) on thin after-hours liquidity following a regular-session close of $2.08. • The price action mirrors similar...
🟢 Connect Biopharma is trading 7.1% up today on light extended-hours activity
Connect Biopharma is trading 7.1% up at $2.25 in after-hours trading, following a modest regular-session dip to $2.10. * The move appears driven by thin...
🟢 Connect Biopharma is trading 5.7% up today amid positive market sentiment and light pre-market volume
Connect Biopharma is trading at $2.26 (+5.7%) in pre-market, rebounding from Friday’s mild decline despite a lack of fresh company-specific news. • The gain...